Next Article in Journal
Serology Identifies LIPyV as a Feline Rather than a Human Polyomavirus
Next Article in Special Issue
SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
Previous Article in Journal
Atypical Hepatitis B Virus Serology Profile—Hepatitis B Surface Antigen-Positive/Hepatitis B Core Antibody-Negative—In Hepatitis B Virus/HIV Coinfected Individuals in Botswana
Previous Article in Special Issue
Do COVID-19 Vaccinations Affect the Most Common Post-COVID Symptoms? Initial Data from the STOP-COVID Register–12-Month Follow-Up
 
 
Article
Peer-Review Record

Immunoglobulin A as a Key Immunological Molecular Signature of Post-COVID-19 Conditions

Viruses 2023, 15(7), 1545; https://doi.org/10.3390/v15071545
by Graziele F. Sousa 1, Raphael M. Carpes 1, Carina A. O. Silva 1, Marcela E. P. Pereira 1, Amanda C. V. F. Silva 1, Viktoria A. G. S. Coelho 1, Evenilton P. Costa 1, Flávia B. Mury 1, Raquel S. Gestinari 1, Jackson Souza-Menezes 1, Manuela Leal-da-Silva 1, José L. Nepomuceno-Silva 1, Amilcar Tanuri 2, Orlando C. Ferreira-Júnior 2 and Cintia Monteiro-de-Barros 1,3,*
Viruses 2023, 15(7), 1545; https://doi.org/10.3390/v15071545
Submission received: 8 June 2023 / Revised: 4 July 2023 / Accepted: 8 July 2023 / Published: 13 July 2023
(This article belongs to the Special Issue COVID-19: Prognosis and Long-Term Sequelae)

Round 1

Reviewer 1 Report

the paper investigates the pathogenetic role of IgA levels in the pathogenesis of the post covid condition. the paper appears to be interesting, however it requires some modifications before publication

in introduction it is not true that the covid became a pandemic at the end of 2020, the pandemic started from the end of the first half of 2020.

the objectives of the study do not according to the title (…describe main symptoms etc… . vs IgA as a key immunological etc).

if IgA is the target analyzed, correlation between symptoms and comorbidity variables and IgA levels should be made.

the discussion must therefore be written highlighting the data emerging from the new analysis. in the discussion it would be useful to speculate on the role of covid drugs that act on IgA (such as pidotimod)  (see doi  10.3390/microorganisms10112131., 10.3390/jcm10245765., 10.4084/MJHID.2020.048.)

Author Response

We thank the reviewers for the comments, all the changes in the article are in red.

Author Response File: Author Response.docx

Reviewer 2 Report

Please provide data with numbers in supplementary tables, including SD, n, mean and statistics.

Provide a table of patient and volunteer demographics, e.g. age, BMI, sex, comorbidities, with mean and SD.

Methods: What type of blood samples were taken? EDTA?

Confirm in the methods section, that OD values were only taken in the linear range of the assay. Best, show an example of the control dilution.

Figure 2B is illegible and should be similar to Figure 1A.

Please state the number of patients analysed  in the legend to Fig 2.

Please always clarify, when total IgG or specific anti SARS-CoV-2 IgG was analysed.

Author Response

We thank the reviewers for the comments, all the changes in the article are in red.

Author Response File: Author Response.docx

Reviewer 3 Report

I am not convinced that measuring immunoglobulin levels tells you antyhing about the goal defined by the authors: "in order to gain a better understanding of the host immune response"

 

r 394. 

what do the authors mean with this part:

 

Authors should discuss the results and how they can be interpreted from the per- 394 spective of previous studies and of the working hypotheses. The findings and their impli- 395 cations should be discussed in the broadest context possible. Future research directions 396 may also be highlighted.

 

 

 

did the authors also look in to RNA levels or prolonged viremia? 

several typo's 

I think parts of the template from viruses are still throughout the text

could benefit from editing by a native speaker. In each part of the manuscript sentences are too long. 

Author Response

We thank the reviewers for the comments, all the changes in the article are in red.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

the authors improved the paper , following the indications provided

Reviewer 2 Report

Please, correct the legend of Fig. 2: "patients 151" into "151 patients"

Thank you for the corrections.

Back to TopTop